Jonathan M. Wilson - Concepedia

Author

Jonathan M. Wilson

Also Known As

J Wilson, J. M. Wilson, J. Mitchell Wilson, J.M Wilson, J.M. Wilson, JONATHAN M. WILSON, Jonathan M Wilson, Jonathan M. Wilson, Jonathan Matthew Wilson, Jonathan Wilson

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Harvard University Indiana University – Purdue University Indianapolis Joslin Diabetes Center University of Michigan

About

Jonathan M. Wilson is an author at Eli Lilly (United States) specializing in medicine, pathology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	744
2	Engineering	1	1	39
3	Health Sciences	1	1	147
4	Natural Sciences	1	1	13
5	Social Sciences	1	1	32

Jonathan M. Wilson

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes Monika A. Niewczas, Meda E. Pavkov, Jan Skupień, Nature Medicine ImmunologyRenal InflammationPathologyInflammationGlomerulonephritis	2019	420
Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes Melissa K. Thomas, Amir Nikooienejad, Ross Bray, The Journal of Clinical Endocrinology & Metabolism	2020	300
The dual glucose‐dependent insulinotropic peptide and glucagon‐like peptide‐1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes Jonathan M. Wilson, Amir Nikooienejad, Deborah A. Robins, Diabetes Obesity and Metabolism	2020	148
Circulating αKlotho influences phosphate handling by controlling FGF23 production Rosamund C. Smith, Linda M. O’Bryan, Emily Farrow, Journal of Clinical Investigation Human GrowthPathologyCellular PhysiologyOsteoporosisFgf Receptors	2012	147
The dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist tirzepatide improves cardiovascular risk biomarkers in patients with type 2 diabetes: A p <scp>ost hoc</scp> analysis Jonathan M. Wilson, Yanzhu Lin, Mengdie Luo, Diabetes Obesity and Metabolism	2021	113
Effects of Tirzepatide, a Dual GIP and GLP-1 RA, on Lipid and Metabolite Profiles in Subjects With Type 2 Diabetes Valentina Pirro, Kenneth D. Roth, Yanzhu Lin, The Journal of Clinical Endocrinology & Metabolism	2021	105
Chronic Hyperphosphatemia and Vascular Calcification Are Reduced by Stable Delivery of Soluble Klotho Julia M. Hum, Linda M. O’Bryan, Arun K. Tatiparthi, Journal of the American Society of Nephrology	2016	88
Follistatin: A Novel Therapeutic for the Improvement of Muscle Regeneration Benjamin C. Yaden, Johnny E. Croy, Yan Wang, Journal of Pharmacology and Experimental Therapeutics	2014	61
Elevated circulating follistatin associates with an increased risk of type 2 diabetes Chuanyan Wu, Yan Borné, Rui Gao, Nature Communications	2021	61
Results of untargeted analysis using the SOMAscan proteomics platform indicates novel associations of circulating proteins with risk of progression to kidney failure in diabetes Hiroki Kobayashi, Helen C. Looker, Eiichiro Satake, Kidney International	2022	47

Page 1